Literature DB >> 6732988

Effects of short term beta adrenoreceptor blockade on serum lipids and lipoproteins in patients with hypertension or coronary artery disease.

M B Murphy, D Sugrue, I Trayner, S Kaufman, H Yasuhara, C T Dollery, G R Thompson.   

Abstract

The effects of beta adrenoceptor blockade with propranolol or pindolol on serum total cholesterol, low density lipoprotein cholesterol (LDL), high density lipoprotein cholesterol (HDL), and its subfractions HDL2 and HDL3, serum triglyceride, and Intralipid clearance were studied in 17 normolipidaemic, non-diabetic patients with hypertension or angina pectoris. Both pindolol and propranolol had similar effects on fasting serum total and lipoprotein cholesterol concentrations. HDL2 cholesterol concentrations were reduced by 9 +/- 29% and HDL3 cholesterol increased by 11 +/- 16%, but there were no significant changes in total or LDL cholesterol in the combined groups after six weeks' treatment. After 12 weeks' treatment total cholesterol concentrations were reduced by 7 +/- 10% mainly owing to a reduction in the LDL fraction of 9 +/- 15%. Concentrations of HDL2 remained low, 8% less than control values. Serum triglyceride concentrations were increased by both drugs at six weeks but had returned to base values in the pindolol group by the twelfth week. Pindolol, but not propranolol, enhanced the rate of clearance of intravenous Intralipid.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6732988      PMCID: PMC481557          DOI: 10.1136/hrt.51.6.589

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  28 in total

1.  Metabolic effects of beta-adrenoreceptor blockers.

Authors:  H J Waal-Manning
Journal:  Drugs       Date:  1976       Impact factor: 9.546

2.  A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.

Authors:  G R Warnick; J J Albers
Journal:  J Lipid Res       Date:  1978-01       Impact factor: 5.922

3.  Effect of chronic administration of propranolol on lipoprotein composition.

Authors:  N Tanaka; S Sakaguchi; K Oshige; T Niimura; T Kanehisa
Journal:  Metabolism       Date:  1976-10       Impact factor: 8.694

4.  High density lipoprotein distribution. Resolution and determination of three major components in a normal population sample.

Authors:  D W Anderson; A V Nichols; S S Pan; F T Lindgren
Journal:  Atherosclerosis       Date:  1978-02       Impact factor: 5.162

5.  Beta-blockers and plasma triglycerides.

Authors:  J Shaw; J D England; A S Hua
Journal:  Br Med J       Date:  1978-04-15

6.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

7.  Total-body potassium in hypertension patients during prolonged diuretic therapy.

Authors:  C J Edmonds; B Jasani
Journal:  Lancet       Date:  1972-07-01       Impact factor: 79.321

8.  A photometric modification of the intravenous fat tolerance test.

Authors:  N Zöllner; W Hansen
Journal:  Atherosclerosis       Date:  1972 May-Jun       Impact factor: 5.162

9.  Serum uric acid in hypertensive patients.

Authors:  C J Bulpitt
Journal:  Br Heart J       Date:  1975-12

10.  The Tromsø heart-study. High-density lipoprotein and coronary heart-disease: a prospective case-control study.

Authors:  N E Miller; D S Thelle; O H Forde; O D Mjos
Journal:  Lancet       Date:  1977-05-07       Impact factor: 79.321

View more
  1 in total

Review 1.  The effects of diuretics and adrenergic-blocking agents on plasma lipids.

Authors:  J J Rohlfing; J D Brunzell
Journal:  West J Med       Date:  1986-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.